Clinical Oncology
Volume 19, Issue 4 , Pages 228-233 , May 2007

The Prognostic Value of Anaemia at Different Treatment Times in Patients with Locally Advanced Head and Neck Cancer Treated with Surgery and Postoperative Radiotherapy

  • B. Dietl

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: Dr B. Dietl, Department of Radiotherapy, Regensburg University Hospital, Franz-Josef-Strauss-Allee 11, D-93042 Regensburg, Germany. Tel: +49-(0)941-9447607; Fax: +49-(0)941-9447612
    • ,
  • J. Marienhagen

      Affiliations

    • Abteilung für Nuklearmedizin, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93042 Regensburg, Germany
    • ,
  • C. Schäfer

      Affiliations

    • Klinik für Strahlentherapie, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93042 Regensburg, Germany
    • ,
  • O. Kölbl

      Affiliations

    • Klinik für Strahlentherapie, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93042 Regensburg, Germany

Received 17 October 2005 ,Revised 23 January 2007 ,Accepted 9 February 2007.

References 

  1. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol. 2000;59:47–53
  2. Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol. 2001;18:243–259
  3. Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev. 1994;13:139–168
  4. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953;26:638–648
  5. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv Exp Med Biol. 1990;277:895–905
  6. Becker A, Hansgen G, Bloching M, Weigel C, Lautenschlager C, Dunst J. Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys. 1998;42:35–41
  7. Molls M, Stadler P, Becker A, Feldmann HJ, Dunst J. Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels. Strahlenther Onkol. 1998;174(suppl 4):13–16
  8. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650–1659
  9. Nordsmark M, Loncaster J, Quino-Parsons C, et al. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol. 2003;67:35–44
  10. Hu K, Harrison LB. Impact of anemia in patients with head and neck cancer treated with radiation therapy. Curr Treat Options Oncol. 2005;6:31–45
  11. Dong Q, Huang J, Zhou Y, et al. Hematogenous dissemination of lung cancer cells during surgery: quantitative detection by flow cytometry and prognostic significance. Lung Cancer. 2002;37:293–301
  12. Kusukawa J, Suefuji Y, Ryu F, Noguchi R, Iwamoto O, Kameyama T. Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. J Oral Pathol Med. 2000;29:303–307
  13. Djulbegovic B. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines. Best Pract Res Clin Haematol. 2005;18:455–466
  14. Lichtin A. The ASH/ASCO clinical guidelines on the use of erythropoietin. Best Pract Res Clin Haematol. 2005;18:433–438
  15. Vaupel P, Mayer A, Hockel M. Impact of hemoglobin levels on tumor oxygenation: the higher, the better?. Strahlenther Onkol. 2006;182:63–71
  16. Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol. 2005;11:14–23
  17. Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer. 2000;82:93–97
  18. Yang FE, Vaida F, Ingacio L, et al. Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:617
  19. Nordsmark M, Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol. 2004;43:396–403
  20. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;59:67–71
  21. Hirst DG, Wood PJ. The adaptive response of mouse tumours to anaemia and retransfusion. Int J Radiat Biol Relat Stud Phys Chem Med. 1987;51:597–609
  22. Hirst DG. Anemia: a problem or an opportunity in radiotherapy?. Int J Radiat Oncol Biol Phys. 1986;12:2009–2017
  23. Cairns RA, Kalliomaki T, Hill RP. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 2001;61:8903–8908
  24. Cairns RA, Hill RP. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res. 2004;64:2054–2061
  25. Reichel O, Panzer M, Wimmer C, Duhmke E, Kastenbauer E, Suckfull M. Prognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumors. Eur Arch Otorhinolaryngol. 2003;260:248–253
  26. van de Pol SM, Doornaert PA, de Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy. Oral Oncol. 2006;42:131–138
  27. Macdonald G, Hurman DC. Influence of anaemia in patients with head and neck cancer receiving adjuvant postoperative radiotherapy in the Grampian region. Clin Oncol (R Coll Radiol). 2004;16:63–70
  28. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003;362:1255–1260
  29. Powles T, Shamash J, Liu W. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet. 2004;363:82
  30. Leyland-Jones B, Mahmud S. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet. 2004;363:80
  31. Haddad R, Posner M. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet. 2004;363:79–80
  32. Vaupel P, Mayer A. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet. 2004;363:992

PII: S0936-6555(07)00523-7

doi: 10.1016/j.clon.2007.02.009

Clinical Oncology
Volume 19, Issue 4 , Pages 228-233 , May 2007

Article Tools